{"efta_number": "EFTA01147594", "page_count": 5, "url": "https://epstein-data.com/EFTA01147594", "pdf_url": "https://epstein-data.com/pdf/EFTA01147594.pdf", "pages": [{"efta_number": "EFTA01147594", "page_number": 0, "text_content": "TERM SHEET \nInvestment in China Medical Data Services Ltd. \nThis term sheet describes the key terms upon which a to-be formed parent company to China \nMedical Data Services Ltd. (the \"Company\") will issue securities (\"Financing\") to a to be \nidentified entity controlled by Dr. Richard Merkin (the \"Investor\" and together with the \nCompany, the \"Parties\"). \nThe Senior Note purchase agreement will reflect that the Financing will close but funds and \nSenior Note will not be released until there exists a signed agreement between Asia Gateway \nHealthcare Information Technology and any governmental party under the jurisdiction of the \nMinistry of Human Resources and Social Security of the P. R. China, having a value of no less \nthan RMB 1 million, for use of the Asia Gateway Healthcare Insurance Information Processing \nAnd Analytics System [to be discussed]. \nThis document is not intended to be a binding agreement of the signatories hereto with respect to \nthe subject matter hereof, except for the provisions contained in Section II. A binding agreement \nwith respect to the proposed terms and conditions in Section I would be subject to, among other \nthings, the Conditions set forth herein. Until execution and delivery of definitive agreements, \nany signatory shall have the absolute right to terminate all negotiations for any reason without \nliability therefor except with respect to the provisions contained in Section II. All dollar amounts \nstated herein are in US dollars. \nThe Parties agree to abide by all applicable law, including laws of the People's Republic of \nChina that apply to the Company's business and all applicable securities laws, in connection with \nthe negotiation of this term sheet, due diligence and issuance and purchase of shares. \nSection I. Non-Binding Proposal of Terms and Conditions \nTopic \nAgreement \nThe Company and its Subsidiary \n[Insert description of holding co] \nChina Medical Data Services Ltd., a company registered in \nHong Kong, is owned 100% by David Stem (\"Stem\"). The \nCompany owns 100% of the shares of Asia Gateway \nHealthcare Information Technology (Beijing) Co Ltd., \nregistered in the People's Republic of China. \nThe Investor \nA to-be identified entity controlled by Dr. Richard Merkin, \nresident in California, U.S.A. \nSenior Debt Securities \nThe Company shall issue Investor a Senior Note with a face \nvalue of US$5 million (the \"Senior Note\"), in consideration \nof US$5 million purchase price paid by Investor. \nAvailability of Funds \nThe consideration will be released to the Company in \nEFTA01147594\n", "char_count": 2570}, {"efta_number": "EFTA01147594", "page_number": 1, "text_content": "immediately available funds and the Senior Note released to \nInvestor immediately upon the Company entering into a \nbinding agreement between Asia Gateway Healthcare \nInformation Technology and any governmental party under \nthe jurisdiction of the Ministry of Human Resources \nand Social Security of the P. R. China, having a value of no \nless than RMB 1 million, for use of the Asia Gateway \nHealthcare Insurance Information Processing And \nAnalytics System. A draft of this agreement, substantially the \nsame as that which will be executed, will be included as an \nexhibit to the definitive documentation. \nInterest on Senior Debt \nSecurities \nThe Senior Note will bear interest at a rate per annum equal \nto 8% of the average outstanding principal of the Senior \nNote, during the applicable interest period. Interest will \ncompound annually. All interest will be paid in kind, in the \nform of additional Senior Note principal. \nSeniority of Senior Debt \nSecurities, Collateral, Guarantees \nand Anti-Layering \nThe Senior Note will be senior in priority to all existing \nindebtedness of the Company and be secured by all \noutstanding stock in all of its subsidiaries as well be issued \nguarantees from all of its subsidiaries. No debt shall be \nissued on a pan pasu basis to the Senior Notes without the \nInvestor's approval. \nDetachable Warrant \nConcurrently with the delivery of the Senior Note, Company \nshall issue to investor a warrant representing, in the \naggregate when converted, 17.5% of the issued and \noutstanding shares of the Company (\"Warrant\"). The strike \nprice of the Warrant shall be US$0.001 and the Warrant shall \nbe exercisable, in whole or in part, at any the time and from \ntime-to-time from the issuance thereof until 10 years \nfollowing such issuance. \nAnti-Dilution Provisions \nThe Warrant shall be appropriately adjusted for stock splits, \nstock dividends and combinations, and similar events. The \nWarrant shall have weighted average anti-dilution protection \nat issuances (or deemed issuances) of Common Stock (or \ncapital appreciation rights or phantom stock). \nVoting Rights \nThe holders of the Warrant shall be entitled to vote on an as \nconverted basis in respect of all matters on which the holders \nof Common Stock are entitled to vote. \nShareholders' Agreement \nThe Parties and Stern shall enter into a shareholders' \nagreement in connection with the issuance and purchase. \nThe shareholders' agreement shall include the following: \n• \nThe Investor shall have the right to designate one \ndirector to the Board of the Company; \n• \nIf the Company seeks to raise additional capital in the \nfuture, the Investor shall have the right of first offer \nEFTA01147595\n", "char_count": 2696}, {"efta_number": "EFTA01147594", "page_number": 2, "text_content": "related to such capital raise \n• \nIf the Investor does not make the additional \ninvestment, Stem and the Investor shall be diluted \npari passe by new shareholders; \n• \nThe Company [or other shareholders or both?] shall \nhave customary \"drag along\" rights; \n• \nThe Investor will have customary \"tag along\" rights \nand demand registration rights with respect to the \nshares underlying the Warrant \n• \nThe Company and Stem will provide customary \nrepresentations required by applicable securities laws; \nand \n• \nThe Company shall agree to certain customary \ncovenants related to an initial public offering of the \nCompany. \nDue Diligence \nThe Investor's obligation to pursue or close the Financing \nwould be conditional upon (in addition to any other items \nidentified in the definitive stock purchase agreement): \n1. \nThe negotiation, approval, execution and \ndelivery of a mutually acceptable stock \npurchase agreement including, among other \nthings, appropriate representations and \nwarranties, indemnifications, conditions and \ncovenants, and such other agreements, \ndocuments and certificates that the Parties \ndetermine are necessary or desirable in \nconnection with the financing (the \"Closing \nDocuments\"); \n2. \nThe completion by the Investor of due \ndiligence investigation of the Company and its \ncorporate structure, business, condition \n(financial and otherwise), operations, assets \nand prospects and the Investor being satisfied \nwith the results of such investigation; \n3. \nInvestor's satisfaction as to the form of \nincorporation and domicile. \n4. \nThe obtaining of all approvals and consents \n(governmental or otherwise) required in \nconnection with the consummation of the \nfinancing, including, but not limited to, any \nappropriate third party consents with respect to \nthe leases, licenses, contracts and agreements \nof the Company; \n5. \nThere having been no material adverse change \nin the Company's business, condition (financial \nEFTA01147596\n", "char_count": 1963}, {"efta_number": "EFTA01147594", "page_number": 3, "text_content": "or otherwise), operations, assets or prospects \nfrom the date of this Term Sheet through \nClosing; and \n6. \nThe receipt by the Investor of such other \ndocuments as may be reasonably requested; \nDispute Resolution \nAll disputes related to the transaction, including those that \nmay arise under the purchase agreement or shareholders' \nagreement, shall be arbitrated exclusively in the London \nCourt of International Arbitration. \nClosing \nThe Parties will use their best efforts to close the Financing \nin the most timely manner reasonable \nSection IL Binding Proposal of Terms and Conditions \nConfidentiality \nThis term sheet, its terms, due diligence and negotiations \nrelated to this term sheet or potential transaction are \nconfidential and are not to be disclosed to third parties by the \nCompany or the Investor without prior written consent of the \nother Party. All terms and conditions contained in the Mutual \nNon-Disclosure and Confidentiality Agreement dated July \n23, 2013, are incorporated herein by this reference. \nLegal Fees and Expenses \nIf the transaction contemplated herein is closed, the \nCompany shall reimburse the Investor for the reasonable fees \nand expenses of Investor counsel and the reasonable fees and \nexpenses of the Investor's financial advisory due diligence, \nsuch fees to be mutually agreed upon by Company and \nInvestors. \nDue Diligence \nFrom the date hereof and prior to the Financing, the \nCompany shall provide the Investor with such information as \nthe Investor may from time to time reasonably request with \nrespect to the Company and its financial condition, results of \noperations, capital resources, prospects, personnel, \naccounting policies and procedures, customer and vendor \nrelationships, and contingencies and commitments. Without \nlimiting the foregoing, the Company shall provide and shall \ncause its subsidiaries to provide, authorize and permit, the \nInvestor and its representatives copies of, or, during regular \nbusiness hours and upon advance notice, reasonable access \nto, all of their properties, books, records, operating \ninstructions and procedures, personnel, financial statements, \ntax returns and all other information with respect to the \nCompany as the Investor may from time to time reasonably \nrequest, including, without limitation, its respective directors, \nofficers, employees, accountants, counsel, suppliers, \ncustomers, and creditors. \nGoverning Law \nThis term sheet is governed by and shall be construed under \nthe laws of California, USA. \nEFTA01147597\n", "char_count": 2534}, {"efta_number": "EFTA01147594", "page_number": 4, "text_content": "Because the Parties are in agreement with the terms stated above and desire to proceed with the \nproposed transaction on that basis, the Parties have executed this term sheet on the \nday of \nSeptember, 2013. \nChina Medical Data Services Ltd. \nBy:  \nIts: \nDr. Richard Merkin \nName: \nEFTA01147598\n", "char_count": 295}]}